Hostname: page-component-848d4c4894-nmvwc Total loading time: 0 Render date: 2024-06-30T19:23:31.616Z Has data issue: false hasContentIssue false
  • English
  • Français

Lupus Anticoagulant, Antiphospholipid Antibodies and Migraine

Published online by Cambridge University Press:  18 September 2015

M.J. Hogan ,
D.G. Brunet ,
P.M. Ford  and
D. Lillicrap
M.J. Hogan
Affiliation:
Department of Medicine, Queen's University, Kingston
D.G. Brunet*
Affiliation:
Department of Medicine, Queen's University, Kingston
P.M. Ford
Affiliation:
Department of Medicine, Queen's University, Kingston Department of Pathology, Queen's University, Kingston
D. Lillicrap
Affiliation:
Department of Medicine, Queen's University, Kingston Department of Pathology, Queen's University, Kingston
*
c/o EEG Department, Kingston General Hospital, Kingston, Ontario, Canada K7L 2V7
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The records of fifteen patients referred for neurological assessment and found to have lupus anticoagulant or elevated anticardiolipin antibodies were reviewed. The mean age for females in the group was 29.4 years and for males was 35. A diagnosis of migraine, either as an acute or chronic problem, was made in 10 (66%) of these patients. Seven of the 15 patients had ischemic stroke and two patients had other thrombotic complications associated with lupus anticoagulant. Three of the nine female patients with migraine had histories of spontaneous abortions. All migraine patients experienced transient or more prolonged neurological deficits with their headaches. An association between lupus anticoagulant and migraine can only be suggested. Data on the incidence of migraine in patients with lupus anticoagulant in the general medical population does not exist. Furthermore the prevalence of lupus anticoagulant in migraine sufferers is unknown. Therefore further studies are required to investigate this possible association.

Type
Original Articles
Information
Canadian Journal of Neurological Sciences , Volume 15 , Issue 4 , November 1988 , pp. 420 - 425
Copyright
Copyright © Canadian Neurological Sciences Federation 1988

References

REFERENCES

1.Conley, CL, Hartmann, RC. A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. Clin Invest 1952; 31: 621–622.Google Scholar
2.Espinoza, LR, Hartmann, RC. Significance of the lupus anticoagulant. Am J Hematol 1986; 22: 331–337.CrossRefGoogle ScholarPubMed
3.Rapaport, SI, Feinstein, DI. Lupus anticoagulant and other hemostatic problems. In: Wallace, DJ, Dubois, EL, eds. Lupus Erythematosus, 3rd Ed. Lea and Febiger 1987: 271–280.Google Scholar
4.Schleider, MA, Nachman, RL, Jaffe, EA, et al. A clinical study of the lupus anticoagulant. Blood 1976; 48: 499–509.CrossRefGoogle ScholarPubMed
5.Gastineau, DA, Kazmier, FJ, Nichols, WL, et al. Lupus anticoagulant: An analysis of the clinical and laboratory features of 219 cases. Am J Hematol 1985; 19: 265–275.CrossRefGoogle ScholarPubMed
6.Bowie, EJW, Thompson, JH, Cascuzzi, PA, et al. Thrombosis in SLE despite circulation anticoagulants. J Lab Clin Med 1963; 62: 416–430.Google Scholar
7.Elias, M, Eldor, A. Thromboembolism in patients with the “Lupus” - type circulating anticoagulant. Arch Intern Med 1984; 144: 510–515.CrossRefGoogle ScholarPubMed
8.Mueh, JR, Herbst, KD, Rapaport, SI. Thrombosis in patients with the lupus anticoagulant. Ann Intern Med 1980; 92: 156–159.CrossRefGoogle ScholarPubMed
9.Boey, ML, Colaco, CB, Gharavi, AE, et al. Thrombosis in systemic lupus erythematosus: Striking association with the presence of circulating anticoagulant. Br Med J 1983; 287: 1021–1023.CrossRefGoogle Scholar
10.Glueck, HI, Kant, KS, Weiss, MA, et al. Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants. Arch Intern Med 1985; 145: 1389–1395.CrossRefGoogle Scholar
11.Harris, EN, Gharavi, AE, Boey, ML, et al. Anticardiolipin antibodies: Detection by radioimmunoassay and association with throbosis in systemic lupus erythematosus. Lancet 1983; 2: 1211–1214.CrossRefGoogle Scholar
12.Colaco, CB, Male, DK. Anti-phospholipid antibodies in syphilis and a thrombotic subset of SLE: Distinct profiles of epitope specificity. Clin Exp Immunol 1985; 59: 449–456.Google Scholar
13.Carreras, LO, Defreyn, G, Machin, SJ, et al. Arterial thrombosis, intrauterine death and “lupus” anticoagulant: Detection of immunoglobulin interfering with prostacyclin formation. Lancet 1981; 1: 244–246.CrossRefGoogle ScholarPubMed
14.Fisher, M, McGehee, W. Cerebral infarct, TIA, and lupus inhibitor. Neurology 1986; 36: 1234–1237.CrossRefGoogle ScholarPubMed
15.Landi, G, Calloni, MV, Sabbadini, MG. Recurrent ischemic attacks in two young adults with lupus anticoagulant. Stroke 1983; 14: 377–379.CrossRefGoogle ScholarPubMed
16.Kelly, RE, Gilman, PB, Kovacs, AG. Cerebral ischemia in the presence of lupus anticoagulant. Arch Neurol 1984; 41: 521–523.CrossRefGoogle Scholar
17.D’Alton, JG, Preston, DN, Bormanis, J, et al. Multiple transient ischemic attacks, lupus anticoagulant and verrucous endocarditis. Stroke 1985; 16: 512–514.CrossRefGoogle ScholarPubMed
18.Baker, WH, Potthoff, WP, Biller, J, et al. Carotid artery thrombosis associated with lupus anticoagulant. Surgery 1985; 8: 612–615.Google Scholar
19.Tabachnick-Schor, NF, Lipton, SA. Association of lupus like anticoagulant and nonvasculitic cerebral infarction. Arch Neurol 1986; 43: 851–852.CrossRefGoogle Scholar
20.Levine, SR, Welch, KMA. Cerebrovascular ischemia associated with lupus anticoagulant. Stroke 1987; 18: 257–263.CrossRefGoogle ScholarPubMed
21.Brandt, KD, Lessell, S. Migrainous phenomena in systemic lupus erythematosus. Arthritis Rheum 1978; 21: 7–16.CrossRefGoogle ScholarPubMed
22.Levine, SR, Joseph, R, D’Andrea, G, et al. Migraine and the lupus anticoagulant. Case reports and review of the literature. Cephalalgia 1987; 7: 93–99.CrossRefGoogle ScholarPubMed
23.Exner, T, Rickard, KA, Kronenberg, H. A sensitive test demonstrating lupus anticoagulant and its behavioral patterns. Br J Haematol 1978; 40: 143–151.CrossRefGoogle Scholar
24.Koike, T, Sueshi, M, Funaki, H, et al. Anti-phospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus. Clin Exp Immunol 1984; 56: 193–199.Google ScholarPubMed
25.Rose, FC. Headache: Definitions and Classification. In: Rose, FC, ed. Handbook of Clinical Neurology, Vol. 4: Headache. Elsevier Science Publishers 1986; 48: 1–12.Google Scholar
26.Ad Hoc Committee on Classification of Headache. Classification of headache. JAMA 1962; 179: 127–128.Google Scholar
27.Ziegler, DK. The headache symptom. How many entities? Arch Neurol 1985; 42: 273–274.CrossRefGoogle ScholarPubMed
28.Bickerstaff, ER. Basilar artery migraine. Lancet 1961; 1: 15–17.CrossRefGoogle Scholar
29.Meyer, O, Piette, J, Bourgeois, P, et al. Anti-phospholipid antibodies: A disease marker in 25 patients with antinuclear antibody negative systemic lupus erythematosus. Comparison with a group of 91 patients with antinuclear antibody positive systemic lupus. J Rheumatol 1987; 14: 502–506.Google Scholar